BB Biotech None

BB Biotech is an equity fund managed by Bellevue Asset Management that invests in global public equity markets. The fund focuses on investing in companies involved in modern biotechnology medications and diagnostics. They use fundamental analysis to create their portfolio and have been in operation since 1993 with headquarters in Switzerland.


Invests into

Estimated Revenue: over $350 billion